#廉貞天府 #桃花帶財 #霍姆斯 #美國惡血 #ElizabethHolmes #Theranos #血液檢驗…
seen from Japan
seen from Germany
seen from United States
seen from United States
seen from Nepal

seen from United States
seen from United States
seen from Singapore
seen from South Korea
seen from China
seen from China
seen from Algeria

seen from United States
seen from China

seen from Germany

seen from Canada

seen from Malaysia

seen from Romania
seen from China
seen from Ecuador
#廉貞天府 #桃花帶財 #霍姆斯 #美國惡血 #ElizabethHolmes #Theranos #血液檢驗…
Youngest self-made female billionaire takes high-tech approach to blood testing Elizabeth Holmes is being compared to visionaries like Bill Gates and Steve Jobs. Holmes founded a biotech company called Theranos in 2003, and her mission is to allow blood testing in every drugstore at a fraction of Medicare costs. Norah O'Donnell reports on how her tiny invention is reshaping health care.
Disgraced Theranos founder Elizabeth Holmes in court Former CEO and billionaire Elizabeth Holmes appeared in court on fraud and conspiracy charges. She's accused of misleading her blood-testing startup investors and faces up to 20 years in prison. #ABCNews #ElizabethHolmes #Theranos
Theranos gets wrist-slap fine from feds, agrees to do no clinical lab work for two years
http://dlvr.it/Nw4QpL
Theranos: ‘Failures in nearly every aspect of laboratory operation’
http://dlvr.it/NKzw7V
Swiss scientists develop subdermal, bluetooth-enabled blood-testing device
This unsuspecting, 14mm long device uses 5 sensors to measure cholesterol, blood sugar levels, and the impact of medical treatments in real time and then sends results to a smartphone using bluetooth technology. This blood-tester can stay implanted for months before needing to be replaced. Though other researchers are developing similar devices, Prof Giovanni de Micheli and lead scientist Sandro Carraraclaim that this implant is unique due to its ability to monitor several markers simultaneously.
The researchers have already started tests on animals and intend to begin testing on intensive care patients that require repeated blood tests. They hope it will be available to patients within four years.